Both NAC and cysteine have limited ability to cross the blood-brain barrier (BBB) [111]
But our base case is that BPC-157, KPV, TB-500, and probably 12 others get through this first round
However, compounding cannot resolve: Unknown long-term biological effects Poorly defined dosing Weak evidence of benefit Inadequate interaction data Immunogenicity or peptide-impurity risks Inappropriate patient selection Marketing claims that exceed the evidence The pathway could also create a new problem if pharmacy availability is interpreted as government endorsement
15,226,227 Recent therapeutic approaches focus on aldose reductase inhibitors (ARIs), such as epalrestat and ranirestat, which have shown promise in reducing sorbitol accumulation and ameliorating neuropathic symptoms in clinical trials
Salicylic acid and rosacea As an exfoliant for rosacea, salicylic acid (aka BHA) has well-established skin-renewing properties, as well as soothing effects that help to reduce breakout-prone skin, redness and discomfort